Monomeric vascular endothelial cadherin (VE-cadherin or cadherin 5) is expressed on tumour neovasculature and progenitor endothelial cells and represents another promising target for altering the vascular microenvironment of GB 92,93. The gene discussed is CDH5; the disease is neoplasm.